The claimEvidence against it: low (plausible mechanism, few human trials)
One sulforaphane pill equals a basket of broccoli
The evidence
Glucoraphanin alone relies on gut bacteria, converting anywhere from 1% to over 40%; outcome trials are small and mixed.
Why the claim spreads
Sulforaphane's mechanism really is elegant in cells and animals, and a supplement skips the chopping, waiting and light steaming. It sounds like a basket of broccoli pressed into one pill.
The mechanism, in brief
A sulforaphane supplement is really selling one step of the conversion path inside broccoli. Check which step before you buy, because it decides how much sulforaphane you end up with.
Sources (6)
- Fahey, J. W., Wehage, S. L., Holtzclaw, W. D., Kensler, T. W., Egner, P. A., Shapiro, T. A., & Talalay, P. (2012). Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prevention Research, 5(4), 603-611.
- Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., et al. (2011). Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prevention Research, 4(3), 384-395.
- Fahey, J. W., Holtzclaw, W. D., Wehage, S. L., Wade, K. L., Stephenson, K. K., & Talalay, P. (2015). Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase. PLoS ONE, 10(11), e0140963.
- Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proceedings of the National Academy of Sciences of the United States of America, 111(43), 15550-15555.
- Zimmerman, A. W., Singh, K., Connors, S. L., Liu, H., Panjwani, A. A., Lee, L. C., et al. (2021). Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Molecular Autism, 12(1), 38.
- Ou, J., Smith, R. C., Tobe, R. H., Lin, J., Arriaza, J., Fahey, J. W., et al. (2024). Efficacy of sulforaphane in treatment of children with autism spectrum disorder: a randomized double-blind placebo-controlled multi-center trial. Journal of Autism and Developmental Disorders, 54(2), 628-641.
Related debunks
- Mega-dose vitamin C prevents coldsEvidence against it: high (guidelines or large endpoint trials)
- An MTHFR variant means you must take active folateEvidence against it: moderate (meta-analyses of mixed quality)
- 'Superfoods' are antioxidant cure-allsEvidence against it: low (plausible mechanism, few human trials)
- Organic food is more nutritious and saferEvidence against it: high (guidelines or large endpoint trials)